000			01380 a2200445 4500
005			20250513131105.0
264		0	_c19980112
008			199801s 0 0 eng d
022			_a0340-6245
040			_aNLM _beng _cNLM
100	1		_aDenninger, M H
245	0	0	_aProspective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis. _h[electronic resource]
260			_bThrombosis and haemostasis _cOct 1997
300			_a1297-8 p. _bdigital
500			_aPublication Type: Comment; Letter
650	0	4	_aAntiphospholipid Syndrome _xcomplications
650	0	4	_aBudd-Chiari Syndrome _xblood
650	0	4	_aComorbidity
650	0	4	_aDisease Susceptibility
650	0	4	_aEnzyme Activation
650	0	4	_aFactor V _xanalysis
650	0	4	_aFemale
650	0	4	_aFrance _xepidemiology
650	0	4	_aGene Frequency
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMyeloproliferative Disorders _xcomplications
650	0	4	_aPortal Vein
650	0	4	_aPrevalence
650	0	4	_aProspective Studies
650	0	4	_aProtein C _xmetabolism
650	0	4	_aRisk Factors
650	0	4	_aThrombophilia _xepidemiology
650	0	4	_aThrombosis _xblood
700	1		_aHelley, D
700	1		_aValla, D
700	1		_aGuillin, M C
773	0		_tThrombosis and haemostasis _gvol. 78 _gno. 4 _gp. 1297-8
999			_c9334968 _d9334968